MONTEVIDEO, Uruguay, March 19, 2018 /PRNewswire/ -- Biotoscana
Gross revenues for 4Q17 grew 14% in constant currency, totaling BRL 271.6M.
Net revenues for 4Q17 increased by 17.8% in constant currency, totaling BRL 244.4M.
Gross profit up 14.4% in 4Q17, in constant currency, totaling BRL 140.3M. Gross margin of 57.4%.
Adjusted EBITDA grew 5.5% in constant currency vs. 4Q16, amounting to BRL 73.2M in 4Q17. 19.2% growth excluding from the base an insurance recovery decoupled from its underlying loss (in 2Q17)
Adjusted net income up 6.9% in nominal terms from 4Q16, reaching BRL 36.9M in 4Q17.
Net revenues for full year 2017 at 817.5M, with 14% organic growth (excluding exchange rate effects, short-term businesses, divestitures and acquisitions).
Adjusted EBITDA reached BRL 199.4M in 2017, up 23.9% in constant currency.
Gross margin for full year 2017 improved 3.8 pp when compared to 2016, reaching 53.8%. Adjusted EBITDA margin improved 2.5 pp, reaching 24.4%, in the same period.
Contacts:Melissa Angeliniir@grupobiotoscana.com +55 11 5090-5927
View original content:http://www.prnewswire.com/news-releases/gbt-reports-fourth-quarter-2017-results-300616306.html
SOURCE Grupo Biotoscana
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All